GlassScriptPhysician profile
Robert J Raymond
NPI 1811343726
$1,635.40
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.46 · 2021: $67.30 · 2022: $325 · 2023: $798 · 2024: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $447.62 | 2021-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered |
| Inari Medical, INC. | $347.99 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Trisalus Life Sciences, INC. | $198.13 | 2023 | Trinav Infusion System |
| Medtronic, INC. | $187.47 | 2022-2023 | Abre |
| Siemens Medical Solutions USA, INC. | $166.14 | 2024 | Acuson Sequoia Diagnostic Ultrasound System |
| W. L. Gore & Associates, INC. | $150.62 | 2023 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Cardiva Medical, INC. | $109.11 | 2023 | Cardiva Vascade 6/7f Vcs |
| Stryker Corporation | $15.86 | 2023 | Spinejack |
| Epizyme, INC. | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Raymond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.